Mario Giuliani
Director/Board Member at HBM HEALTHCARE INVESTMENTS AG
Net worth: 311 M $ as of 2024-04-29
Network origin in Mario Giuliani first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 15 | |
| Venture Capital Fund | Investment Managers | 10 | |
ElevateBio LLC
 ElevateBio LLC BiotechnologyHealth Technology ElevateBio LLC is a biotechnology holding company, which creates and operates a broad portfolio of cell and gene therapy companies. It builds single and multi-product companies by providing scientific founders with bench-to-bedside capabilities including scientists, manufacturing facilities, drug developers, and commercial expertise. The company was founded by David L. Hallal, Vikas Sinha, and Mitchell H. Finer and is headquartered in Cambridge, MA.
8
| Holding Company | Biotechnology | 8 |
MIKA Pharma GmbH
 MIKA Pharma GmbH Pharmaceuticals: MajorHealth Technology MIKA Pharma GmbH develops and produces dermal, transdermal and buccal application systems. It serves pharmaceuticals on the basis of sprayable liposomes, pre-liposomal solutions and proprietary micellar nano-solutions. The company was founded in 1994 and is headquartered in Speyer, Germany.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Nogra Pharma Invest SARL
1
| Subsidiary | 1 | |
Fair-Med Healthcare AG
 Fair-Med Healthcare AG Pharmaceuticals: OtherHealth Technology Fair-Med Healthcare AG manufactures generic medicines. It offers prescription and over-the-counter drugs across several therapeutic segments. The company was founded in 2012 and is headquartered in Zug, Switzeland.
1
| Subsidiary | Pharmaceuticals: Other | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mario Giuliani via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MORGAN STANLEY | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Sales & Marketing | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
General Atlantic LLC
 General Atlantic LLC Investment ManagersFinance General Atlantic LLC (General Atlantic) is a private equity firm founded in 1980 by Charles F. Feeney. The firm is headquartered in New York. | Investment Managers | Chief Executive Officer Chairman | |
HBM Partners AG
 HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Investment Managers | Chief Executive Officer Director of Finance/CFO | |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| RADIUS HEALTH, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Private Equity Investor Private Equity Investor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Doctorate Degree | |
| BLUEBIRD BIO, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| The Johns Hopkins University | College/University | Director/Board Member Doctorate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Graduate Degree | |
| Princeton University | College/University | Doctorate Degree Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree | |
| University of New Hampshire | College/University | Undergraduate Degree | |
Pfizer Venture Investments LLC
 Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments LLC (Pfizer Ventures Investments) is a venture capital subsidiary of Pfizer Inc. founded in 2001. The firm is headquartered in New York. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Hospital/Nursing Management | Director/Board Member Director/Board Member | |
Council on Foreign Relations, Inc.
 Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
The Partnership for New York City, Inc.
 The Partnership for New York City, Inc. Miscellaneous Commercial ServicesCommercial Services The Partnership for New York City operates as a charitable organization. It is a network of business leaders and corporations working for the economic and cultural betterment of all five boroughs of the city. The firm provides networking opportunities, conducts research, participates in policy making and lobbies government. The company was founded by David Rockefeller in 2002 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| University of Basel | College/University | Doctorate Degree Graduate Degree | |
| Johann Wolfgang Goethe-Universität Frankfurt am Main | College/University | Doctorate Degree Undergraduate Degree | |
| University of Bern | College/University | Doctorate Degree Doctorate Degree | |
Intracel Holdings Corp.
 Intracel Holdings Corp. BiotechnologyHealth Technology Intracel Holdings Corp. engages in the development of vaccines and diagnostic products for cancer and infectious diseases. The company was founded in 2013 and is headquartered in Frederick, MD. | Biotechnology | Chief Executive Officer | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
| CANDEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Founder | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
TriNetX, LLC
 TriNetX, LLC Medical/Nursing ServicesHealth Services TriNetX, Inc. provides an online data network for collaborative research. It enables hospitals, academic medical centers, physician networks, practices, and pharmaceuticals to participate in collaborative research and a public and private sustainability model for research informatics. The company was founded by Bard Geesaman in 2013 and is headquartered in Cambridge, MA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| NEXTCURE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ONCORUS, INC. | Biotechnology | Chief Executive Officer | |
| TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| ALLOVIR, INC. | Biotechnology | President Director/Board Member Director/Board Member Chairman | |
CODA Biotherapeutics, Inc.
 CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology CODA Biotherapeutics, Inc. engages in the development of chemo genetic neuromodulation platform for the treatment of severe neurological disorders. The company was founded by Mitchell H. Finer, Allan Basbaum, Nicholas Boulis, Joseph Glorioso III and Kenneth P. Greenberg in 2014 and is headquartered in South San Francisco, CA. | Medical Specialties | Founder | |
General Atlantic Service Co. LP
 General Atlantic Service Co. LP Financial ConglomeratesFinance General Atlantic Service Co. LP engages in provision of investment services. It specializes in consumer, financial services, healthcare, and technology sectors. The company was founded by Chuck Feeney in 1980 and is headquartered in New York, NY. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
| Elevatebio Base Camp, Inc. | President | ||
| ITEOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman | |
Orna Therapeutics, Inc.
 Orna Therapeutics, Inc. BiotechnologyHealth Technology Orna Therapeutics, Inc. is a biotechnology company that designs and delivers fully engineered circular RNA therapeutics to treat diseases. Orna Therapeutics is based in Cambridge, MA, and has subsidiaries in the United States. The company's proprietary platform combines novel technology to create RNA that drives protein expression with validated and unique delivery solutions. Orna has many advantages over traditional approaches, including simplified production, improved formulatability, and superior protein expression. The company was founded by Daniel Anderson, Raffaella Squilloni, Alex Wesselhoeft, and the CEO is Thomas M. Barnes. | Biotechnology | Chairman Director/Board Member | |
| TURMERIC ACQUISITION CORP. | Financial Conglomerates | Director/Board Member | |
| CULLINAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Renagade Therapeutics, Inc.
 Renagade Therapeutics, Inc. BiotechnologyHealth Technology Renagade Therapeutics, Inc. is an American US-based company that aims to overcome the limitations of RNA medicines by applying their comprehensive deliver, code, edit, insert technologies to precisely correct disease on an unprecedented scale. The company has developed a broad portfolio of RNA delivery systems, which profoundly expand the array of addressable diseases. The company's proprietary, synergistic toolkit allows them to precisely deliver, code, edit, and insert RNA medicines to treat any disease, anywhere in the body. Renagade is built on a foundation of proprietary delivery technologies to unlock previously inaccessible cells, reprogramming cells with superior expression using the leading RNA coding platform via joint venture with Orna Therapeutics, enabling curative therapies by permanently correcting defective genes with proprietary technology, and industry-leading all-RNA system to enable exon or large gene insertions as a gene therapy 2.0 platform. Renagade is backed by MPM BioImpact and F2 Ventures, leading financial groups who have supported the development of over 50 products to market. | Biotechnology | Founder Director/Board Member | |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Abata Therapeutics, Inc.
 Abata Therapeutics, Inc. BiotechnologyHealth Technology Abata Therapeutics, Inc. is a biotech company based in Watertown, MA. Abata Therapeutics is focused on developing engineered Treg cell therapies for severe autoimmune and inflammatory diseases. The American company's lead programs are in ind-enabling studies for progressive multiple sclerosis and type 1 diabetes, both of which are tissue-specific autoimmune diseases with significant unmet needs. The company has developed a differentiated product engine to create tissue-specific, robust, and durable therapies. Abata Therapeutics was launched by Third Rock Ventures, with participation from a diverse syndicate of investors, including ElevateBio, Lightspeed Venture Partners, Invus, Samsara Biocapital, and the JDRF T1D Fund. The company was founded in 2021 by Richard Ransohoff and the CEO is Samantha Singer. | Biotechnology | Director/Board Member |
Statistics
International
| United States | 44 |
| Switzerland | 4 |
| Ireland | 2 |
| Mexico | 2 |
| Germany | 2 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 11 |
| Finance | 9 |
| Health Services | 3 |
| Miscellaneous | 2 |
Operational
| Director/Board Member | 384 |
| Independent Dir/Board Member | 95 |
| Corporate Officer/Principal | 82 |
| Chairman | 75 |
| Chief Executive Officer | 52 |
Most connected contacts
| Insiders | |
|---|---|
| Ansbert Gadicke | 56 |
| William Ford | 49 |
| Robert Alexander Ingram | 43 |
| Elaine Jones | 37 |
| David Hodgson | 34 |
| Rory Riggs | 32 |
| Ted Love | 31 |
| Hans-Peter Hasler | 28 |
| Mitchell Finer | 26 |
| Leopoldo Giampaolo Zambeletti | 22 |
| Andreas Wicki | 21 |
| Errol de Souza | 21 |
| Bonnie Bassler | 20 |
| Navneet Govil | 20 |
| Henry Fernandez | 20 |
- Stock Market
- Insiders
- Mario Giuliani
- Company connections
